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Abstract
Brr2 is a DExD/H-box helicase responsible for U4/U6 unwinding during spliceosomal activation. 
Brr2 contains two helicase-like domains, each of which is followed by a Sec63 domain with 
unknown function. We determined the crystal structure of the second Sec63 domain, which 
unexpectedly resembles domains 4 and 5 of DNA helicase Hel308. This, together with sequence 
similarities between Brr2’s helicase-like domains and domains 1–3 of Hel308, led us to 
hypothesize that Brr2 contains two consecutive Hel308-like modules (Hel308-I and II). Our 
structural model and mutagenesis data suggest that Brr2 shares a similar helicase mechanism with 
Hel308. We demonstrate that Hel308-II interacts with Prp8 and Snu114 in vitro and in vivo. We 
further find that the C-terminal region of Prp8 (Prp8-CTR) facilitates the binding of the Brr2/Prp8-
CTR complex to U4/U6. Our results have important implications for the mechanism and 
regulation of Brr2’s activity.
Keywords
Pre-mRNA splicing; Brr2; Sec63; Hel308; Prp8; Snu114
Pre-mRNA splicing is carried out by the spliceosome, which contains five small nuclear 
RNAs (snRNAs U1, U2, U4, U5, and U6) and over 100 different proteins. The spliceosome 
typically assembles on pre-mRNA in a step-wise manner 1. In the first step of spliceosomal 
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assembly, the 5’ splice site (ss), Branch Point Sequence (BPS), and 3’ss of pre-mRNA are 
recognized by the U1 snRNP, SF1/BBP, and U2AF65/35, respectively. Subsequently, U2 
snRNP joins the spliceosome, followed by the joining of the U4/U6.U5 tri-snRNP. 
Extensive structural rearrangements occur at this stage 2. For example, the base-pairing 
between the 5’ss and U1 snRNA is disrupted and the 5’ss interacts with U6 instead. The 
base-pairing between U4 and U6 is also disrupted and new interactions between U2 and U6 
are formed. These rearrangements help convert the spliceosome to the catalytically active 
complex, which subsequently splices out the intron and ligate the two exons.
At least eight DExD/H-box proteins are involved at various stage of the splicing cycle 3. 
DExD/H-box proteins contain many RNA helicases and belong to helicase superfamily 2 
(SF2). All superfamily 1 (SF1) and 2 helicases contain the minimal helicase domain (two 
RecA domains with ~400 amino acids encompassing at least eight conserved helicase 
motifs) and sometimes additional domains 4,5. Motifs I and II are highly conserved among 
all SF1 and SF2 helicases but other motifs are less so and are often used to classify SF1 or 
SF2 helicases into smaller families. DExD/H-box proteins can be further divided into 
DEAD, DEAH, Ski2-like DExH, and a few other families 4. Multiple DExD/H-box proteins 
in the spliceosome have been demonstrated to have weak helicase activity in vitro 6–10. 
While their precise molecular targets remain largely unknown, the DExD/H-box proteins are 
thought to facilitate the many conformational rearrangements required for the successful 
assembly and activation of the spliceosome 3.
Brr2 is a large DExD/H-box protein (2,163 amino acids in yeast) and a stable component of 
the U5 snRNP 7,11,12. Early experiments identified a role for Brr2 in the unwinding of 
U4/U6, a critical step in spliceosomal activation 7,11,12. Recent work supports a role for 
Brr2 in unwinding of U2/U6 during spliceosomal disassembly 13. As an integral component 
of the U5 snRNP, tri-snRNP, and spliceosome 14, regulation of Brr2’s helicase activity is 
particularly important to ensure the correct timing of spliceosomal activation or 
disassembly. Prp8 and Snu114 (both components of the U5 snRNP, tri-snRNP, and 
spliceosome) have been implicated in regulating the activity of Brr2 2,13,15–17. For 
example, Brr2’s in vitro ATPase and helicase activities are modulated by the C-terminal 
region of Prp8, although the site of modulation on Brr2 and the mechanism of modulation 
are not yet known 18.
To our knowledge, Brr2 is a the only DExD/H-box protein that contains two putative 
helicase domains, with the second helicase-like domain deviating more from the 
prototypical helicase motifs 14,19,20. Whereas the motifs in the first helicase-like domain of 
S. cerevisiae Brr2 (yBrr2) have been shown to be critical for ATPase activity, U4/U6 
unwinding, and cell viability, the motifs in the second helicase domain can be disrupted with 
little consequence 12. Brr2 also contains multiple other domains, including an N-terminal 
domain and two Sec63 domains. The five domains are arranged as shown in Figure 1a and 
are abbreviated as N, H1, S1, H2, and S2. The Sec63 domain is defined by sequence 
similarity with Sec63 protein, a central component of the protein translocation apparatus on 
the ER membrane, although the structure and function of the Sec63 domain are unknown 21. 
With the exception of the H1 domain which is likely involved in RNA unwinding, the 
function of the other Brr2 domains is unclear.
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In this paper, we determined the crystal structure of S2 of yBrr2, and find unexpected 
structural similarity between S2 and domains 4 & 5 of Hel308 (a Ski2-type SF2 DNA 
helicase implicated in DNA repair and recombination). This structural similarity, in 
combination with sequence analyses, led us to hypothesize that the entire Brr2 protein is 
composed of an N-terminal domain and two consecutive Hel308-like modules. This model 
offers our first glimpse of the overall structure of this large and unique spliceosomal ATPase 
and helicase. The structural similarity with Hel308 suggests mechanistic similarities 
between Brr2 and Hel308, which are consistent with mutagenesis data. We further 
demonstrated that the second Hel308-like module interacts with Prp8 and Snu114 in vitro 
and in vivo. We also show that the C-terminal region of Prp8 (Prp8-CTR, residues 1822–
2395) facilitates the binding of the Brr2/Prp8-CTR complex to U4/U6, and discuss the 
implications of this result for the activity and regulation of Brr2.
Results
The crystal structure of S2 suggests two consecutive Hel308 modules in Brr2
We determined the crystal structure of S2 to 2.0 Å resolution, which shows that S2 is 
composed of three domains, an N-terminal helical domain, a middle helical domain, and a 
C-terminal beta domain with the fibronectin type 3 (Fn3) fold (Fig. 1b, Supplementary Fig. 
1). The overall structure of yeast Brr2 S2 is highly similar to the human Brr2 S2 domain 
(PDB ID 2Q0Z, Northeast Structural Genomics Consortium) (Fig. 1c). The root mean 
square deviation of 269 superimposed main chain atoms between the two structures is 1.6Å, 
consistent with the sequence similarity between the two S2 domains (Supplementary Fig. 2). 
All of our subsequent discussion will use the yBrr2 S2 structure we determined.
In spite of the lack of obvious sequence similarity, a structural homology search using the 
Dali server 22 revealed that the two helical domains of S2 have exactly the same topology as 
domains 4 and 5 of Hel308, a Ski2-type SF2 DNA helicase 23,24 (PDB ID 2P6R) (Fig. 1d). 
Hel308 also contains two RecA domains (domain 1 and 2) and another helical domain 3 (86 
residues). The H2 regions of Brr2 share sequence similarity with the two RecA domains 
common to all SF2 helicases including Hel308 14,20. In addition, we noticed that there are 
~120 residues immediately downstream of the second RecA domain in H2 that is all helical, 
based on secondary structure predictions 25. Therefore, the H2 region of Brr2 could 
resemble domains 1–3 of Hel308 in three-dimensional structures and the H2+S2 region of 
Brr2 resembles the entire Hel308 with an additional Fn3 domain (Fig. 1e).
The S1 domain of Brr2 likely forms a similar structure to the S2 domain, considering their 
sequence similarities. Secondary structure predictions of S1 and S2 match well with the 
actual secondary structures observed in the S2 structure (Supplementary Fig. 1), supporting 
the hypothesis that S1 forms a similar structure to S2. It is also known that the H1 domain 
has substantial sequence similarity to the Ski2-type helicase domains (higher than that 
between H2 and these helicases) 14. It is, therefore, highly likely that the H1+S1 region also 
forms a structure similar to Hel308. Taken together, we propose that the overall structural of 
Brr2 consists of an N-terminal domain and two consecutive Hel308-like modules (Hel308-I 
and II) (Fig. 1e).
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The structural model of Hel308-I suggests possible helicase mechanisms
Hel308-I likely serves the unwinding function based on previous mutagenesis studies 12. 
Hel308-I has the highest sequence conservation among different species, with 35% identity 
among yeast, human, C. elegans, Drosophila, and Arabidopsis Brr2, while 9% of the 
residues in the N-terminal domain and 18% of the residues in Hel308-II are absolutely 
conserved (MULTALIN 26, data not shown). The high degree of sequence conservation in 
Hel308-I is likely a reflection of the critical importance of the helicase activity of this 
module.
A model of Brr2 Hel308-I can be built based on the crystal structure of Hel308 in complex 
with a partially unwound DNA duplex (15bp dsDNA with a 10nt 3’ overhang) 23 (Fig. 1e). 
The proposed unwinding mechanism of Hel308 is substantially different from many well-
studied DEAD-box RNA helicases. A prominent β-hairpin between motifs V and VI in 
domain 2 of Hel308 disrupts two base pairs of the dsDNA (Supplementary Fig. 3a) and is 
thought to be important for strand separation 23. DEAD-box RNA helicases such as eIF4A 
27, UAP56 28,29, and Vasa 30 do not have a similar β-hairpin and use local RNA bending 
as a different unwinding mechanism 30. Sequence alignment shows that motifs V and VI of 
Brr2 are similar to Hel308, but are drastically different from eIF4A (Supplementary Fig. 
3b). Brr2 Hel308-I contains a similar number of residues between motifs V and VI as in 
Hel308 (Supplementary Fig. 3b), making it feasible for Hel308-I to also form a similar β-
hairpin in this region, although it is often difficult to accurately predict a short β-hairpin 
based on secondary structure predictions. The sequence between motifs V and VI in Brr2 
and Hel308 are not well conserved, but it does not necessarily conflict with the potential 
functional importance of this region, since many different amino acid compositions may 
form a β-hairpin.
As a first step toward exploring the functional importance of the putative β-hairpin region, 
we generated a brr2-3GS mutant by replacing residues 860–865 (WEQLSP, downstream of 
an existing Gly-Ser pair) with three additional sets of Gly-Ser (Supplementary Fig. 3b). Gly-
Ser residues have often been used to create flexible linkers in protein engineering 31. We 
reason that this stretch of four Gly-Ser residues will likely disrupt any potential β-hairpin 
structure in this region, although we realize that the 3GS mutant could potentially be too 
drastic and disrupt the overall structure of Brr2. We generated brr2-3GS on the pGPD-
BRR2-TAP vector (containing a C-terminal Protein A tag) and shuffled it into the yTB105 
strain (endogenous brr2 deleted and WT brr2 on an URA3-marked plasmid) 18. brr2-3GS 
grows much slower than WT at 30 °C and 18 °C and does not grow at 37 °C (Supplementary 
Fig. 3c). We showed that the Brr2 protein levels in the WT and brr2-3GS strains are similar 
by pulling down Brr2 proteins from cell extracts using IgG resin followed by Western blot 
analyses using an anti-Brr2 antibody 32 (Supplementary Fig. 3c). We also demonstrated that 
Brr2-3GS pulls down similar amounts of Prp8 and Snu114 as WT Brr2 (Supplementary Fig. 
3c), suggesting that the 3GS mutant has not caused major disruption of the overall structure 
of Brr2. We then purified WT Brr2 and Brr2-3GS proteins using IgG resin and cleaved off 
the Protein A tag with TEV protease. As we purified away Brr2-associated proteins, 
Brr2-3GS became more prone to degradation and resulted in less full-length protein than 
WT Brr2 (~20% of WT level) (Supplementary Fig. 3d). The full-length Brr2-3GS no longer 
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has in vitro ATPase and helicase activity 18 (data not shown). Although the loss of helicase 
activity could be a combination of the effect of the putative β-hairpin itself and other 
structural changes caused by the 3GS mutation (noting that Brr2-3GS is more prone to 
degradation in purification and also lost ATPase activity), these results do suggest that the 
putative β-hairpin region is important for the structure and/or function of Brr2. Further 
structural, mutagenesis (for example, scanning single-site mutants in the putative β-hairpin 
region), and biochemical analyses will unambiguously reveal whether Brr2 contains a β-
hairpin and utilizes an unwinding mechanism similar to Hel308.
Hel308 is also a processive DNA helicase, in contrast with typical DExD/H-box RNA 
helicases. In the Hel308+DNA structure, the ssDNA goes through the enclosure formed by 
domains 1, 3 & 4 and also interacts with domains 2 and 5 (ref. 23). It was suggested that the 
presence of domains 3 & 4, as well as a central ratchet helix in domain 4, contribute to the 
processivity of Hel308. Our structural model suggests that similar domains and the ratchet 
helix also exist in Hel308-I of Brr2, suggesting Brr2 may be more processive than other 
typical DExD/H-box proteins involved in splicing.
Two previously identified brr2 mutants are located in the Hel308-I module. Brr2-1 (E610G) 
and Brr2-R1107A are cs mutants that are defective in U4/U6 unwinding 11 and/or 
spliceosome disassembly 13. Residue E610 is located in motif Ib (TPEK in Brr2) of domain 
1, which is typically involved in RNA or DNA substrate binding 23,30. The equivalent E123 
residue of Hel308 is indeed on a helix right next to the ssDNA in the Hel308+DNA structure 
23 (Fig. 2a). Interestingly, Hel308-W599 (the equivalent of Brr2-R1107, Supplementary 
Fig. 1) is on the midpoint of the ratchet helix of domain 4, across from motif 1b (Brr2-E610) 
on the opposite side of the same ssDNA (Fig. 2a). Hel308-W599 forms a stacking 
interaction with the 5th base of the ssDNA. Two helical-turns away, Hel308-R592 on the 
same helix interacts with the 3rd base of the ssDNA. In addition, the N-terminus of the 
ratchet helix interacts with motif IVa of domain 2.
Therefore, ATP-dependent movement of domain 2 was thought to modulate the position of 
the ratchet helix and facilitate strand translocation 23. Brr2-F1100 (the equivalent of 
Hel308-R592) in combination with Brr2-R1107 (the equivalent of Hel308-W599) can 
potentially perform a similar function to Hel308-R592 and Hel308-W599 in strand 
translocation and processivity. Mutations of Brr2-E610 (i.e., brr2-1) and Brr2-R1107 (i.e., 
brr2-R1107A) may conceivably affect RNA binding and/or strand translocation, and 
consequently affect U4/U6 unwinding and spliceosomal disassembly. Indeed, Brr2-1 does 
not have detectable unwinding activity in an in vitro helicase assay 18. To test the role for 
R1107 in Brr2 function, we constructed the R1107A mutant on the pGPD-BRR2-TAP 
vector and shuffled the mutant plasmid into the yTB105 strain. We were able to purify a 
similar quantity of Brr2 R1107A and Brr2 WT (Fig. 2b) for ATPase and helicase assays. As 
previously observed 18, WT Brr2 demonstrates weak helicase activity on its own, but the 
activity is greatly stimulated by Prp8-CTR (the previously used Prp8 region consists of 
residues 1806–2413 and is highly similar to our Prp8-CTR consisting of residues 1822–
2395) (Fig. 2c). WT Brr2 also demonstrates RNA stimulated ATPase activity which is 
inhibited by Prp8-CTR (Fig. 2d, e). We found that the Brr2 R1107A mutant has greatly 
reduced ATPase activity and no detectable helicase activity under the current assay 
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conditions (Fig. 2c–e). Both Brr2-1 and R1107A likely retain weak helicase activity in vivo 
since yeast strains containing these mutants grow similarly to WT at 30 °C. In general, these 
results support the mechanistic similarity between Brr2 and Hel308.
Domain deletions in Hel308-II are lethal or detrimental to growth
In contrast to the likely unwinding function of Hel308-I, the Hel308-II module of Brr2 does 
not have ATPase activity and is unlikely to have helicase activity 12. We focused our 
subsequent studies on understanding the function of Hel308-II. We generated yeast strains 
carrying Brr2 with the H2, S2, or Hel308-II (H2+S2) domains deleted. These deletions were 
constructed on pPR150 (carrying a C-terminal polyoma tag) 11 and were shuffled into yeast 
strain yJPS996 (endogenous brr2 deleted and WT brr2 on an URA3-marked plasmid) 13. 
The S2-deletion strain grows much slower than WT at all three temperatures (Fig. 3a). All 
other deletion strains do not grow on 5-FOA plates (Fig. 3b), indicating that these deletions 
are lethal. We then performed pull down experiments using yeast extract and an anti-
polyoma antibody, followed by Western blotting with an anti-Brr2 antibody 32. There are 
similar quantities of Brr2 protein in both the WT and S2-deletion strain (Fig. 3c), indicating 
that the slow growth phenotype of the S2-deletion is not caused by the lack of Brr2 protein. 
We also performed similar pull down experiments using yeast strains prior to 5-FOA 
shuffling. The H2 and Hel308-II deletion strains have much less Brr2 protein than the WT 
strain, indicating that these deletions destabilize the Brr2 protein (Fig. 3d).
The S2 deletion affects the splicing of many genes
To examine the molecular phenotype of the S2 deletion, we performed splicing-specific 
microarray experiments. These microarrays contain three probes for each of the ~300 intron-
containing genes in yeast: one targeting a region of the intron to measure pre-mRNA levels, 
one targeting the junction between exons 1 and 2 to measure the mature mRNA, and one 
targeting a region of either exon 1 or 2 to measure changes in total mRNA 33. As a control, 
we simultaneously examined the behavior of the brr2-1 strain 11. The microarray data show 
that the S2 deletion affects the splicing of the vast majority of intron-containing genes, as 
demonstrated by the accumulation of pre-mRNA and reduction of spliced mRNA for these 
genes (Fig. 3e).
The defects seen in the S2 deletion, both in terms of the number of transcripts that are 
affected, and the magnitude to which their splicing is affected, are similar in scale to the 
defects seen in the brr2-1 strain (Fig. 3e), indicating a strong defect in pre-mRNA splicing. 
Interestingly, the S2 deletion, but not the brr2-1 mutation, also showed accumulation of U1, 
U2, and U5 snRNAs (1.9, 3.5, and 2.6 fold, respectively) through quantitative RT-PCR 
analyses (Fig. 3f). The mechanism and significance of this accumulation await further 
studies.
Hel308-II does not bind several RNAs tested in vitro
We next examined whether Hel308-II retains the ability to bind to RNA, even though it 
lacks ATPase and helicase activities. We demonstrated using Electrophoresis Mobility Shift 
Assay (EMSA) that purified Hel308-II does not bind a 13nt ss or ds RNA 
(GAGAUUUAUUUCG, arbitrary sequence, designated as ssR13 and dsR13) even at a 
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concentration of 50 µM, in the absence or presence of ATP (Fig. 4a). Under similar 
conditions, the positive control UAP56 (a splicing factor and DEAD -box protein) clearly 
binds RNA at 10 µM concentration in the presence of ATP (ATP is known to increase the 
RNA binding affinity of many DEAD-box proteins including eIF4A 30,34) (Fig. 4a). Nor 
does Hel308-II have detectable binding to U4/U6 at 5 µM protein concentration in the 
presence or absence of ATP (Fig. 4b, lanes 1 and 2).
Hel308-II interacts with Prp8 and Snu114 in vitro
We then evaluated whether the Hel308-II module can potentially function as a protein 
interaction domain and mediate interactions with other spliceosomal proteins. We performed 
in vitro GST pull down experiments using GST-fused versions of several Brr2 domains, 
Prp8 domains, and Snu114 as baits, and HA-tagged Brr2 H2, S2, or Hel308-II domains as 
prey (Fig. 5a). These experiments demonstrate that the H2 and S2 domain of Brr2 interact 
with each other, consistent with the idea that the H2 and S2 domains come together to form 
a Hel308 module. Furthermore, the H2, S2, and Hel308-II domains all interact with both the 
N-terminal (residues 233–518) and C-terminal (Prp8-CTR, residues 1822–2395) regions of 
Prp8, as well as with Snu114. These interactions are specific as no interaction is detected 
with GST alone. Our results are consistent with previous observations using yeast two-
hybrid analyses that the C-terminal region of yBrr2 (a construct containing the combination 
of residues 112–356 and 1184–2163) is responsible for the vast majority of interactions 
between Brr2 and many spliceosomal proteins including Prp8 (ref. 35). The interactions 
between the H2 domain of hBrr2 and hPrp8 as well as hSnu114 have also been observed 
previously using yeast two-hybrid analyses 36,37.
The S2 deletion decreases Brr2’s association with Prp8 and Snu114 in vivo
We took advantage of the fact that the S2-deletion strain is viable to examine whether the S2 
domain also interacts with Prp8 and Snu114 in vivo. We immunoprecipitated Brr2 from 
extracts of the WT and S2-deletion strains using an anti-polyoma antibody. We then 
performed Western blot analyses on the immunoprecipitated sample using anti-Brr2 32, 
anti-Prp8 38, and anti-Snu114 39 antibodies. The level of Brr2 protein in the 
immunoprecipitated sample from the S2-deletion strain is similar to WT, but the level of 
Prp8 and Snu114 are much less in the S2-deletion strain (about 50% of the WT level) (Fig. 
5b). These experiments demonstrate that S2 deletion is defective in Prp8 and Snu114 
binding, suggesting that the S2 domain indeed participates in Prp8 and Snu114 interactions 
in vivo.
The S2 deletion reduces the ATPase and helicase activity of Brr2 in vitro
To evaluate the effects of the S2 deletion on the ATPase and helicase activity of Brr2, we 
replaced the WT brr2 in the pGPD-Brr2-TAP vector 18 with the S2-deleted brr2. We 
expressed the full-length and S2-deleted Brr2 from yeast strain yTB105 16 and purified 
proteins using IgG resin and cleaved off the Protein A tag with TEV protease. We obtained 
similar quantities of purified proteins (Fig. 2b) for ATPase and helicase assays. The S2 
deletion reduces Brr2’s ATPase and helicase activities to levels that are undetectable in 
these assays (Fig. 2c–e). The S2-deleted Brr2 is likely to still have weak ATPase and 
Zhang et al. Page 7
Nat Struct Mol Biol. Author manuscript; available in PMC 2010 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
helicase activities in vivo, since the S2-deletion strain is viable even though it grows much 
slower than the WT strain. These results suggest that the S2 domain and Hel308-I interact/
communicate with each other, and the S2 domain potentially stabilizes the structure and 
conformation of Hel308-I. The S2-deletion does not seem to lead to a complete mis-folding 
of Brr2, since the S2-deletion strain is still viable and we can purify similar quantities of 
soluble S2-deleted Brr2 protein as WT Brr2 protein (Fig. 2b). However, the S2-deletion 
probably leads to certain conformational changes in Hel308-I, rendering it less active in 
ATPase and helicase assays.
Prp8-CTR facilitates the binding of the Brr2/Prp8-CTR complex to U4/U6
We then examined the effect of Prp8-CTR on the RNA binding property of Brr2, using both 
Hel308-II and full-length Brr2. We showed using EMSA that Brr2 Hel308-II does not bind 
U4/U6 appreciably at 5 µM concentration (Fig. 4b, lane 2). Prp8-CTR, on the other hand, 
essentially binds and shifts all of the U4/U6 at 5 µM concentration (Fig. 4b, lane 4). We 
performed a titration experiment and determined that the Kd of Prp8-CTR to U4/U6 is 
2.2±0.2 µM (Fig. 4c). This affinity is substantially higher than the affinity of Prp8-CTR to 
ssR13 and dsR13, where 13 µM Prp8-CTR shows essentially no binding to ssR13 and very 
little binding to dsR13 (Fig. 4d). When Brr2 Hel308-II and Prp8-CTR are incubated together 
with U4/U6, nearly all of the U4/U6 shifts to a position that is different from the band 
formed by Prp8-CTR alone + U4/U6 (Fig. 4b, compare lane 3 with lane 4). We interpreted 
this new gel-shift band as the Prp8-CTR + Hel308-II + U4/U6 complex (Fig. 4b, lanes 3).
The full-length Brr2 does not show appreciable binding to U4/U6 at 0.7 µM concentration 
(Fig. 4b, lanes 5 and 6). The addition of 0.7 µM Prp8-CTR in lane 8 forms a band at the 
same position as the Prp8-CTR alone + U4/U6 band in lane 7, and importantly, a new 
slower migrating band that likely corresponds to the Prp8-CTR + Brr2 + U4/U6 complex. 
Supershift experiments using anti-Prp8 38 and anti-Brr2 32 antibodies (Fig. 4b, lanes 11–13) 
confirmed our assignment of the faster migrating band as Prp8-CTR alone + U4/U6 and the 
slower migrating band as Prp8-CTR + Brr2 + U4/U6. The addition of more Prp8-CTR (lane 
10) continues to form a band corresponding to the Prp8-CTR alone + U4/U6 band in lane 9 
and a new band that likely represents the Prp8-CTR + Brr2 + U4/U6 complex. Note the 
positions of the Prp8-CTR alone + U4/U6 bands are somewhat different at 0.7 µM and 2 µM 
Prp8-CTR concentrations (compare lane 7 with 9) for reasons we do not yet fully 
understand, and this phenomenon is also observed in the Kd determination experiment in 
Fig. 4c. All binding reactions are highly reproducible and were performed both in the 
absence and presence of ATP, yielding identical results (data not shown). These results 
indicate that Prp8-CTR can facilitate the binding of the Brr2/Prp8-CTR complex to U4/U6.
Discussion
Our structural studies in combination with sequence analyses suggest that the H2+S2 
domain of Brr2 resembles the entire Hel308 and that the full length Brr2 protein is 
composed of an N-terminal domain and two consecutive Hel308-like modules (Hel308-I and 
II). A recent structure of another Ski2-type DNA helicase Hjm also revealed a similar 
domain structure and organization as Hel308 40. This raises the possibility that many Ski2-
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type helicases may share structural (and potentially mechanistic) similarities in regions 
beyond the helicase domains, in spite of the lack of recognizable sequence similarities in 
these regions.
The structural resemblance between Brr2 and Hel308 suggests possible helicase 
mechanisms for Brr2. Our brr2-3GS mutant suggests that the putative β-hairpin region in 
Brr2 Hel308-I is structurally and/or functionally important. Further structural and mutational 
analyses will reveal whether Brr2 indeed contains a β-hairpin and utilizes an unwinding 
mechanism similar to Hel308 30. Furthermore, our structural mapping and biochemical 
analyses of the brr2-1 and brr2-R1107A mutants support the structural and mechanistic 
similarity between Brr2 and Hel308. These results suggest the possibility that Brr2 is more 
processive than other DExD/H-box proteins involved in pre-mRNA splicing. This potential 
processivity is attractive considering that yBrr2 needs to unwind U4/U6, which contains 
long stem regions and is highly stable in yeast 41.
Brr2 is the only known helicase that contains two helicase-like modules. The function of the 
second helicase-like module has long been elusive and intriguing. There are several 
substantial deviations between the putative helicase motifs in Hel308-II and the canonical 
helicase motifs. For example, the typical DExD/H residues in motif II are replaced with 
DDAH in Hel308-II (Supplementary Fig. 4). The Glu of motif II (DExD/H) has been 
postulated to be the key catalytic residue which activates a water molecule to hydrolyze 
ATP in DExD/H-box proteins and other helicases 5,30,42. Likewise, the Ser-Ala-Thr (SAT) 
residues in motif III are replaced with SNC in Hel308-II (Supplementary Fig. 4). The SAT 
residues in motif III do not interact with ATP or RNA but participate in inter-domain 
interactions between the N-terminal and C-terminal domains upon ATP and RNA binding 
and are thought to be important for the unwinding activity of DExD/H-box proteins 30. 
Hel308-II also lacks obvious motifs IV – VI (Supplementary Fig. 4). Substantial deviations 
from the canonical helicase motifs in Hel308-II probably have led to the lack of ATPase and 
helicase activities of this module.
We demonstrated that Hel308-II interacts with Prp8 and Snu114 in vitro and in vivo (Fig. 5a, 
7). We do not rule out the possibility that Prp8 and Snu114 also interact with the Hel308-I 
module, although we cannot yet test this hypothesis since Hel308-I alone is unstable. It is 
worth noting that protein-tag labeling and antibody recognition approaches have mapped the 
C-terminus of Brr2 to be somewhat distant from the C-terminus of Prp8 in the EM 
projection structure of the yeast tri-snRNP, while the C-termini of Prp8 and Snu114 are in 
close proximity to each other 43. However, these labeling methods are designed to map the 
extreme C-terminus of a protein. The longest dimension of Hel308 is about 80Å and the 
Prp8-CTR can reach similar dimensions depending on the relative orientation of its C-
terminal and β-finger domains 37,44–47. This dimension can easily span the distance 
between the C-termini of Brr2 and Prp8 observed in the EM structure 43. Therefore, the 
main body of Brr2 Hel308-II and Prp8-CTR can overlap and interact with each other even if 
the extreme C-termini of Brr2 and Prp8 are far from each other. Our results, in general, 
represent the first example of a helicase-like structural fold serving as a major protein-
interaction platform.
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The Hel308-II module can potentially play a role in mediating the regulation of Brr2 
activity. Recently, it was shown that the C-terminal fragment of Prp8 (residues 1806–2413) 
greatly stimulates Brr2’s helicase activity but inhibits its ATPase in vitro 18. Here we 
showed that the deletion of S2 results in a dramatic reduction of Brr2’s ATPase and helicase 
activity (Fig. 2c–e). We also found that the deletion of Hel308-II drastically destabilizes the 
protein (Fig. 3d). Both results suggest that the S2 domain as well as the entire Hel308-II 
module interact and communicate with Hel308-I. It is foreseeable that the interaction 
between Prp8 and Hel308-II can potentially affect the structure and/or stability of Hel308-I 
and consequently the ATPase and helicase activity of Brr2. We do not rule out the 
possibility that Prp8 may directly interact with Hel308-I to modulate Brr2’s activity. Either 
directly (through Hel308-I) or indirectly (through Hel308-II), Prp8 can potentially affect 
Brr2’s ATPase and helicase activities through increasing RNA binding affinity, stabilizing a 
favorable conformational change, increasing processivity, or a combination of the above. In 
analogous situations, detailed kinetic analyses suggest that eIf4B, eIF4H, and eIF4G 
stimulate eIF4A’s ATPase and helicase activity through one or more of the above 
mechanisms 48. Likewise, Ntr1 was recently shown to stimulate the activity of Prp43 
(another DExD/H-box protein involved in spliceosome disassembly) and was thought to 
affect Prp43’s processivity 49.
Our observation of the effect of Prp8-CTR on Brr2’s RNA binding property raises another 
interesting possibility for the regulation of Brr2’s activity. We showed that Prp8-CTR binds 
U4/U6 with a much higher affinity than arbitrary 13nt ss or ds RNAs (Fig. 4c, d). When 
Prp8-CTR and Brr2 (Hel308-II or full-length protein) are combined, the complex binds 
U4/U6 much better than Brr2 alone (Fig. 4b). We cannot differentiate at this point whether 
Prp8-CTR increases Brr2’s intrinsic affinity to U4/U6 or the increased binding is solely 
attributed to Prp8-CTR in the complex. However, in either case, the interaction between 
Prp8-CTR and Brr2 clearly helps the complex bind U4/U6 better. This increased affinity 
provides a possible mechanism for how Prp8-CTR helps Brr2 to confer specificity toward 
U4/U6. Further studies will reveal the extent of this specificity, such as how stringent the 
Prp8-CTR is toward the sequence and/or structure of U4/U6. It is worth noting that Ritchie 
et al. found that the N-terminal RNase H domain of the human Prp8-CTR has a much higher 
binding affinity with a U2/U6 mimic than other RNAs 46, consistent with the possibility that 
Prp8 may also help Brr2 confer specificity toward U2/U6 to facilitate Brr2’s role in U2/U6 
unwinding. The higher local concentration of U4/U6 brought to Brr2 by Prp8-CTR could 
also serve as an additional mechanism for the stimulation effect by Prp8-CTR we observed 
in vitro. There are other enzymes (such as collagen prolyl 4-hydroxylase, HIV integrase, and 
endonuclease NaeI) that have separate substrate binding and catalytic domains, especially 
when the substrate is a polypeptide or oligonucleotide 50–52. Prp8 can potentially serve as 
an auxiliary substrate-binding and specificity domain for Brr2.
Our results also lead to reflections on the function of the Sec63 domain in general. Our 
structural result shows that the so-called Sec63 domain is in fact made of three domains, two 
helical and one all-beta Fn3 domains. The Sec63 domain has at least two functions. It can 
serve as a major RNA binding and processivity domain as in the case of Hel308-I. It can 
also serve as a major protein interaction domain as in the case of Hel308-II. The Fn3 fold in 
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the Sec63 domain belongs to the immunoglobulin-like superfamily whose members are 
almost always involved in binding functions 53. Deletion of the Sec63 domain in the Sec63 
protein leads to impaired higher-order complex formation 54. This Sec63 domain may also 
play a role in protein interaction, indicating the generality of the Sec63 domain serving as a 
protein interaction domain.
Methods
Yeast strain and plasmids
The brr2-3GS, bbr2-1, and R1107A mutations were generated on the pGPD-Brr2-TAP 
vector 18 using the QuikChange Site-Directed Mutagenesis Kit (Stratagene) and all 
mutations were confirmed by DNA sequencing of the entire Brr2 coding region. The 
mutated plasmid was shuffled into pTB105 and its growth phenotype was compared to WT 
brr2 on the same plasmid in pTB105. Brr2 deletion constructs on pPR150 11 were generated 
by amplifying the pPR150 plasmid without the deletion region, using PCR primers 
containing a common restriction site for subsequent digestion and ligation. A similar 
strategy was used to generate the S2-deleted brr2 on the pGPD-Brr2-TAP vector. The WT 
and truncated pPR150 plasmids were shuffled into yeast strain yJPS996 13 (gift of J. Staley, 
University of Chicago) for growth phenotype or pull down analyses.
Protein expression and purification
The Brr2 S2 domain was sub-cloned into the pGEX-6p1 vector (GE Healthcare) and 
expressed in E. coli strain XA90 as a GST-fusion protein. The fusion protein was first 
purified using glutathione Sepharose resin and cleaved using PreScission protease. The 
resultant S2 domain was further purified on a Superdex-200 (S200) gel-filtration column 
(GE Healthcare) and concentrated to 10 mg ml−1 for crystallization trials. Se-Met 
substituted S2 domain was expressed in minimal medium containing Se-Met. The protein 
was then purified using glutathione resin, a Resource Q column (GE Healthcare), followed 
by the S200 column. The purified protein was concentrated to 12 mg ml−1 for crystallization 
trials.
The Brr2 H2 and H2+S2 domain used for RNA binding experiments and the HA-tagged H2, 
S2, and H2+S2 domains used for GST-pull down experiments were also sub-cloned into the 
pGEX-6p1 vector, expressed and purified similarly as the S2 domain. The GST-fused Brr2, 
Prp8 and Snu114 proteins used in GST-pull down experiments were obtained similarly 
without the PreScission cleavage and gel-filtration purification.
WT and mutated Brr2 were expressed in yeast strains yTB105 containing the pGPD-BRR2-
TAP or pGPD-BRR2-mutant-TAP plasmids and were purified as previously described 18 
with the following exceptions. The frozen cell paste was homogenized with a SPEX 
SamplePrep 6870 Freezer Mill. The proteins were cleaved off the IgG resin using TEV and 
dialyzed into the storage buffer (20 mM Hepes pH7.9, 100 mM NaCl, 5 mM BME, 0.2 mM 
EDTA, 0.01% (v/v) NP-40, 20% (v/v) glycerol) for subsequent enzymatic and EMSA 
analyses.
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Crystallization, data collection, and structure determination
The Brr2 S2 domain was crystallized by the hanging drop vapor diffusion method using a 
well solution containing 0.1 M Sodium Citrate (pH 6.0), 17% PEG8000, and 0.2 M NaCl. 
All crystallographic data were collected at 100K using the Molecular Biology Consortium 
beamline 4.2.2 of the Advanced Light Source at Lawrence Berkeley National Laboratory. 
Data were processed using the d*trek package 55 and data statistics are shown in Table 1.
The structure of S2 was determined using the Se-Met MAD method and programs Solve and 
Resolve 56. Model building was carried out using O 57. Refinement was performed using 
CNS 58 and the peak data set. Refinement statistics are shown in Table 1. 90.2% and 9.8% 
of the residues fall into the most favored and additionally allowed regions and no residues 
are in the generously allowed and disallowed regions of the Ramachandran plot.
ATPase and helicase assays
ATPase and helicase assays were performed as previously described 18 except that 250 nM 
Brr2 proteins and 1 µM U4/U6 were used in ATPase assays. The helicase assay contains 25 
nM Brr2, 250 nM Prp8-CTR, and 200 nM U4/U6.
Splicing microarray
To monitor pre-mRNA splicing defects on a global scale, whole genome splicing 
microarrays analyses were performed as described 59. Samples for both the brr2-ΔS2 strain 
and its matched wild type strain were collected at 30°C for splicing microarray analyses. 
Samples for the brr2-1 strain and its matched wild type were collected after shifting to 16°C 
for 10 minutes.
Quantitative RT-PCR
Quantitative RT-PCR was performed as described 59. The reaction was performed using a 
Roche LightCycler 480 and the following primers. Sample loading was normalized 
according to the composite behavior of the YMR286w and YAL010c genes.
GENE FORWARD Primer REVERSE primer
U1 TGACTACTTTTCTCTAGCGTGCC CATAACGGGAACGAGCAAAGTTG
U2 AACTGAAATGACCTCAATGAGGCTC AGACCTGACATTAGCGGAAAACAAC
U4 ATCCTTATGCACGGGAAATACG AAAGGTATTCCAAAAATTCCCTAC
U5 CAAGCAGCTTTACAGATCAATGG AGTTCCAAAAAATATGGCAAGCC
U6 GTTCGCGAAGTAACCCTTCG AAAACGAAATAAATCTCTTTGTAAAAC
YMR286w GTTGAGTAGGTCGCTTATCGGTGT CTTTTACTTTAGCTAGGGAGCCAGC
YAL010c ATAGCTACGAGGATATAACGGCCA AATTGCTGTGCATCGGAGTATAAAT
Protein and RNA interaction using Electrophoresis Mobility Shift Assay (EMSA)
Short 13nt RNA oligos (ssR13 and its complementary sequence) were ordered from 
Integrated DNA Technologies. ssR13 was 5’-end-labeled with 32P-γ-ATP using Optikinase 
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(USB Corporation). dsR13 was generated by combining labeled ssR13 and its 
complementary sequence, boiling for three minutes, and cooling to room temperature in 
about three hours. U4 was in vitro transcribed from pT7U4 linearized with Sty1 using T7 
RNA polymerase and in the presence of α-32P-UTP 60. U6 was transcribed from 
pT7U6(ΔU) (first two Us removed from U6 to increase transcription efficiency) linearized 
with Dra1 8. Both RNAs were purified by extraction from a 6% (w/v) Urea-TBE denaturing 
polyacrylamide gel, phenol:chloroform extraction, and ethanol precipitation. The U4/U6 
duplex were generated by combining U4 and U6 RNAs in 40 mM Tris-HCl pH7.4 and 100 
mM Sodium Acetate, boiling for three minutes, and cooling to room temperature in about 
three hours.
RNA was incubated on ice with protein (UAP56, Prp8-CTR, and various Brr2 proteins) in 
20 µl of 10 mM Hepes, pH7.6, 1 mM MgCl2, 100 mM NaCl, 5% glycerol, and in the 
absence or presence of 1 mM ATP for 60 minutes. In supershift experiments, anti-Brr2 or 
anti-Prp8 antibody was added in the binding reaction after 30 minutes and was incubated for 
another 30 minutes on ice. The reaction mixture was separated on a 4% native 
polyacrylamide gel in TBE buffer (for short 13nt RNAs) or Hepes buffer (20 mM Hepes, 
pH7.9 for U4/U6), visualized and quantified using a phosphorimager.
GST-pull down experiments
GST-fused Snu114, Brr2 and Prp8 fragments were incubated with glutathione resin at 4 °C 
for 2 hours in the binding buffer (50 mM Tris-HCl, pH7.5, 120 mM NaCl, 0.2% NP40, 10% 
glycerol, 2 mM EDTA, 1 mM DTT, 1 mg ml−1 BSA) and washed with the wash buffer (50 
mM Tris-HCl, pH8, 100 mM NaCl, 0.5% NP40, and 1 mM EDTA) for three times. Resin 
carrying equal quantity of fusion protein were incubated with HA-tagged Brr2 domains (H2, 
S2, or H2+S2) at 4 °C for 2 hours. The resin were washed four times with the low salt buffer 
(50 mM Tris-HCl, pH7.5, 120 mM NaCl, 0.2% NP40, 10% glycerol, 2 mM EDTA, 1 mM 
DTT) and three more times with the high salt buffer (same as the low salt buffer with the 
exception of containing 500 mM NaCl and 0.5% NP40). The resin was then analyzed using 
Western blot with an anti-HA antibody.
Co-Immunoprecipitation
Yeast strains were grown to OD600 of 1.0. 20 OD cells were harvested by centrifugation, 
washed with 1 ml of buffer A (10 mM HEPES, pH 7.9, 100 mM NaCl, 5 mM Benzamidine, 
2 mM PMSF, 5 mM NEM, 2 mM EDTA), and resuspended in 200 µl of buffer B (0.1% 
Deoxycholic acid, 1 mM EDTA, 50 mM HEPES-KOH, pH7.5, 140 mM NaCl, 1% (w/v) 
Triton X-100, 1 mM PMSF, 1×protease inhibitors cocktail (Roche). Cells were lysed using 
the bead beater and separated using centrifugation. The supernatant containing 1.6 mg total 
proteins was incubated with 5ul anti-polyoma antibody (Covance) overnight at 4 °C. 30 µl 
protein G agarose (GE Healthcare) was added to the mixture and incubated at 4 °C for 2 
hours. The resin was washed with buffer B four times. The resin was then run on a 6% SDS 
polyacrylamide gel and analyzed using Western blot with specific antibodies.
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Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
The structure of yBrr2. (a) A schematic representation of the domain organization 
(abbreviations shown in parenthesis) of yBrr2. (b) Overall structure of the S2 domain, 
colored in rainbow spectrum from the N-terminus (blue) to the C-terminus (red). (c) 
Superimposition of the yeast (cyan) and human (yellow, PDB ID 2Q0Z) S2 domain 
structures. (d) Superimposition of the S2 domain and domains 4 and 5 of Hel308 (yellow, 
PDB ID 2P6R 23). The N-terminal helical domain, the middle helical domain, and the C-
terminal Fn3 domain in S2 are colored blue, green, and purple, respectively. (e) A backbone 
model (by combining the Hel308 and S2 structure) depicting the overall structure of Brr2 
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consisting the NTD, Hel308-I, and Hel308-II. In each Hel308-like module, the D1-6 
domains are colored in dark blue, light blue, green, purple, orange, and red, respectively. A 
partially unwound DNA duplex (black) as seen in the Hel308 structure was modeled in 
Hel308-I to represent the RNA substrate. The traditional H2 and S2 domain were indicated 
in ovals on the structural model.
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Fig. 2. 
ATPase and helicase activities of Brr2 mutants. (a) Locations of residues corresponding to 
brr2-1 (E610G) and brr2-R1107A on the Hel308 structure (PDB ID 2P6R 23) and their 
relationship with the ssDNA (black). Color scheme is the same as 1e. (b) SDS PAGE of 
purified Brr2 WT, R1107A, and Brr2 S2del mutants. (c) Helicase assay of WT Brr2, Brr2 
R1107A, and Brr2 S2del, in the absence and presence of Prp8-CTR. (d) ATPase activity of 
WT Brr2, Brr2 R1107A, and Brr2 S2del in the absence and presence of Prp8-CTR and 
U4/U6. (e) Quantification of the data in panel g. Error bars indicates s.e.m.
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Fig. 3. 
Deletions of domains in Hel308-II lead to growth and splicing defects. (a) S2 deletion grows 
slower than the WT brr2 strain in all three temperatures. Five-fold Serial dilutions were 
plated on YEPD plates and grown at 30 °C and 37 °C for 2 days and at 18 °C for 5 days. (b) 
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A 5-FOA plate demonstrating that the S2-deletion is viable but H2 and Hel308-II deletions 
are lethal. (c) Pull down experiments using yeast extract and an anti-polyoma antibody, 
followed by Western analyses using an anti-Brr2 antibody, showed that the cellular Brr2 
protein levels are similar in the WT and S2-deletion strains. (d) Similar pull down 
experiments using strains prior to 5-FOA shuffling showed that H2 or Hel308-II deletions 
led to dramatically reduced Brr2 protein levels. (e) Microarray and quantitative RT-PCR 
analyses of the genome-wide splicing phenotype and snRNA levels of the S2-deletion strain. 
Each horizontal line describes the behavior of a single intron-containing gene. T, P, and M 
represent total mRNA, pre-mRNA, and mature mRNA, respectively. Yellow indicates 
increased and blue indicates decreased RNA levels compared to the WT. (f) Total snRNA 
levels assessed using quantitative RT-PCR indicates that the S2 deletion leads to an 
accumulation of the U1, U2 and U5 snRNAs. Error bars indicate s.d.
Zhang et al. Page 22
Nat Struct Mol Biol. Author manuscript; available in PMC 2010 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Zhang et al. Page 23
Nat Struct Mol Biol. Author manuscript; available in PMC 2010 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 4. 
The interaction of Brr2 with RNA and the effect of Prp8-CTR on these interactions. (a) 
EMSA demonstrates that Hel308-II does not bind a 13nt ss or dsRNA with arbitrary 
sequence (GAGAUUUAUUUCG) in the absence or presence of ATP. UAP56, another 
DExD/H-box protein involved in splicing, is used as a positive control and binds both ss and 
dsRNA in the presence of ATP. (b) Hel308 (lanes 1–4) and full-length Brr2 (lanes 5–10) do 
not bind U4/U6 at indicated concentrations but the presence of Prp8-CTR generate a 
complex that binds U4/U6 better. Supershift experiments using anti-Brr2 and anti-Prp8 
antibodies confirm the identity of the shifted bands (lanes 11–13). (c) Titration experiments 
indicate that Prp8-CTR binds U4/U6 with a Kd of 2.2±0.2 µM. Error bars and errors in Kd 
are s.d. d) Prp8-CTR binds ss or dsR13 very weakly.
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Fig. 5. 
Hel308-II interacts with Prp8 and Snu114 in vitro and in vivo. (a) GST pull down 
experiments demonstrate that the H2, S2, and Hel308-II domains interact with Prp8 and 
Snu114. (b) Co-immunoprecipitation experiments demonstrate that the S2-deletion strain 
has similar level of Brr2 but lower level of Prp8 and Snu114 than WT strains. Brr2 in yeast 
extract was pulled down using anti-polyoma antibody and probed in Western blot using anti-
Brr2, anti-Prp8 and anti-Snu114 antibodies. Error bars indicate s.d.
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Table 1
Data collection, phasing and refinement statistics.
Brr2 S2 1
Data collection
Space group P212121
Cell dimensions
  a, b, c (Å) 55.15, 75.68, 83.96
  α,β,γ (°) 90, 90, 90
Peak Inflection Remote
Wavelength (Å) 0.979 0.9789 0.964
Resolution (Å) 40-2.0 (2.07-2.00) 2 40-2.0 (2.07-2.00) 40-2.0 (2.07-2.00)
Rsym or Rmerge 0.084 (0.414) 0.076 (0.422) 0.082 (0.494)
I / σI 10.7 (3.9) 12.0 (3.9) 10.3 (2.9)
Completeness (%) 100.0 (100.0) 100.0 (100.0) 100.0 (100.0)
Redundancy 7.2 (7.3) 7.2 (7.1) 7.2 (7.1)
Refinement
Resolution (Å) 30-2.0
No. reflections 45,120
Rwork / Rfree 0.246/0.257
No. atoms
  Protein 2,482
  Ligand/ion 0
  Water 192
B-factors
  Protein 36.28
  Ligand/ion
  Water 36.27
R.m.s deviations
  Bond lengths (Å) 0.008
  Bond angles (°) 1.674
1One crystal was used for data collection at all three wavelengths. 
2Values in parentheses are for highest-resolution shell.
Nat Struct Mol Biol. Author manuscript; available in PMC 2010 January 01.
